Clinical Trial Update: Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating sildenafil for intrauterine growth restriction (IUGR) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction
• Intrauterine Growth Restriction

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University of British Columbia | Conditions: Intrauterine Growth Restriction (IUGR), Fetal Growth Restriction (FGR) | Phase 2, Phase 3 | Status: TERMINATED